We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Maryland

News List

BioNTech Acquires Kite’s Neoantigen TCR Cell Therapy R&D Platform and Manufacturing Facility in Maryland americanpharmaceuticalreview
August 05, 2021
BioNTech SE and Kite, a Gilead Company announced the closing of the acquisition of the solid tumor neoantigen T cell receptor (TCR) R&D platform and clinical manufacturing facility’s assets and leases in Gaithersburg, MD, from Kite.
Vigene Plans Major Expansion in Maryland contractpharma
February 09, 2021
Vigene Biosciences, a global gene therapy development company, has unveiled plans to expand into a new facility in Montgomery County in Maryland to accommodate industry demand for its gene and cellular therapy products.
Vineti Opens New Regional HQ in Maryland contractpharma
May 29, 2019
New office expansion further enables accelerated cell and gene therapy clinical development and commercial operations in the Eastern United States.